Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors

Tim S. Veth,Nynke M. Kannegieter,Erik L. de Graaf,Rob Ruijtenbeek,Jos Joore,Anna Ressa,Maarten Altelaar
DOI: https://doi.org/10.1016/j.drudis.2024.103907
IF: 8.369
2024-02-02
Drug Discovery Today
Abstract:The development of protein kinase inhibitors (PKIs) has gained significance owing to their therapeutic potential for diseases like cancer. In addition, there has been a rise in refining kinase activity assays, each possessing unique biological and analytical characteristics crucial for PKI development. However, the PKI development pipeline experiences high attrition rates and approved PKIs exhibit unexploited potential because of variable patient responses. Enhancing PKI development efficiency...
pharmacology & pharmacy
What problem does this paper attempt to address?